| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | high-affinity L-glutamate transmembrane transporter activity | 6.17e-09 | 5 | 120 | 4 | GO:0005314 | |
| GeneOntologyMolecularFunction | glutamate:sodium symporter activity | 6.17e-09 | 5 | 120 | 4 | GO:0015501 | |
| GeneOntologyMolecularFunction | sodium ion transmembrane transporter activity | SLC6A18 ASIC2 SLC1A1 SLC1A2 SLC1A6 SLC1A7 SLC8A2 SLC9C1 SLC9A3 CACNA1I CACNA1H | 6.82e-09 | 171 | 120 | 11 | GO:0015081 |
| GeneOntologyMolecularFunction | amino acid:sodium symporter activity | 2.22e-07 | 23 | 120 | 5 | GO:0005283 | |
| GeneOntologyMolecularFunction | amino acid:monoatomic cation symporter activity | 7.63e-07 | 29 | 120 | 5 | GO:0005416 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | SLC6A18 ASIC2 PKDREJ SLC1A1 SLC1A2 SLC1A6 SLC1A7 RYR3 SLC41A2 SLC8A2 SLC9C1 SLC9A3 CACNA1I CACNA1H | 8.00e-07 | 465 | 120 | 14 | GO:0046873 |
| GeneOntologyMolecularFunction | L-glutamate transmembrane transporter activity | 1.61e-06 | 15 | 120 | 4 | GO:0005313 | |
| GeneOntologyMolecularFunction | calcium ion binding | PCDHGA2 FAT3 PCDHB15 PCDHA13 CDH23 PCDHA8 PCDHA6 PKDREJ LRP1B ITIH4 RYR3 HEG1 DST HMCN1 VCAN PCDH15 ADGRE4P | 2.46e-06 | 749 | 120 | 17 | GO:0005509 |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 4.54e-06 | 41 | 120 | 5 | GO:0015175 | |
| GeneOntologyMolecularFunction | acidic amino acid transmembrane transporter activity | 5.58e-06 | 20 | 120 | 4 | GO:0015172 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | SLC6A18 ASIC2 PKDREJ SLC1A1 SLC1A2 SLC1A6 CHRNA2 SLC1A7 RYR3 SLC41A2 SLC8A2 SLC9C1 SLC9A3 CACNA1I CACNA1H | 1.07e-05 | 664 | 120 | 15 | GO:0008324 |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC6A18 SLC35E1 SLC7A6 SLC1A1 SLC1A2 SLC1A6 SLC1A7 SLC8A2 SLC9C1 SLC9A3 | 1.22e-05 | 296 | 120 | 10 | GO:0015291 |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | SLC6A18 ASIC2 PKDREJ SLC1A1 SLC1A2 SLC1A6 SLC1A7 RYR3 SLC41A2 SLC8A2 SLC9C1 SLC9A3 CACNA1I CACNA1H | 2.45e-05 | 627 | 120 | 14 | GO:0022890 |
| GeneOntologyMolecularFunction | transporter activity | SLC6A18 ATP8B3 ASIC2 ATP8A2 SLC35E1 SLC7A6 PKDREJ SLC1A1 SLC1A2 AQP9 SLC1A6 CHRNA2 SLC1A7 RYR3 SLC41A2 CLPTM1L SLC8A2 SLC9C1 SLC9A3 CACNA1I CACNA1H | 2.59e-05 | 1289 | 120 | 21 | GO:0005215 |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 4.12e-05 | 105 | 120 | 6 | GO:0015171 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC6A18 ASIC2 PKDREJ SLC1A1 SLC1A2 AQP9 SLC1A6 SLC1A7 RYR3 SLC41A2 SLC8A2 SLC9C1 SLC9A3 CACNA1I CACNA1H | 4.97e-05 | 758 | 120 | 15 | GO:0015318 |
| GeneOntologyMolecularFunction | organic acid:sodium symporter activity | 5.62e-05 | 35 | 120 | 4 | GO:0005343 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 6.84e-05 | 71 | 120 | 5 | GO:0015179 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC6A18 ASIC2 PKDREJ SLC1A1 SLC1A2 SLC1A6 CHRNA2 SLC1A7 RYR3 SLC41A2 SLC8A2 SLC9C1 SLC9A3 CACNA1I CACNA1H | 8.25e-05 | 793 | 120 | 15 | GO:0015075 |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 1.07e-04 | 3 | 120 | 2 | GO:0008332 | |
| GeneOntologyMolecularFunction | cysteine transmembrane transporter activity | 1.07e-04 | 3 | 120 | 2 | GO:0033229 | |
| GeneOntologyMolecularFunction | solute:sodium symporter activity | 1.28e-04 | 81 | 120 | 5 | GO:0015370 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC6A18 ASIC2 SLC35E1 SLC7A6 PKDREJ SLC1A1 SLC1A2 AQP9 SLC1A6 CHRNA2 SLC1A7 RYR3 SLC41A2 SLC8A2 SLC9C1 SLC9A3 CACNA1I CACNA1H | 2.38e-04 | 1180 | 120 | 18 | GO:0022857 |
| GeneOntologyMolecularFunction | prostaglandin E receptor activity | 3.54e-04 | 5 | 120 | 2 | GO:0004957 | |
| GeneOntologyMolecularFunction | active monoatomic ion transmembrane transporter activity | 4.74e-04 | 301 | 120 | 8 | GO:0022853 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 4.97e-04 | 26 | 120 | 3 | GO:0005248 | |
| GeneOntologyMolecularFunction | carboxylic acid binding | 6.09e-04 | 239 | 120 | 7 | GO:0031406 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC6A18 SLC35E1 SLC7A6 SLC1A1 SLC1A2 SLC1A6 SLC1A7 SLC8A2 SLC9C1 SLC9A3 | 6.14e-04 | 477 | 120 | 10 | GO:0022804 |
| GeneOntologyMolecularFunction | hyaluronic acid binding | 6.90e-04 | 29 | 120 | 3 | GO:0005540 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 7.63e-04 | 119 | 120 | 5 | GO:0015294 | |
| GeneOntologyMolecularFunction | organic acid binding | 8.71e-04 | 254 | 120 | 7 | GO:0043177 | |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 1.25e-03 | 9 | 120 | 2 | GO:0090556 | |
| GeneOntologyMolecularFunction | channel activity | ASIC2 PKDREJ SLC1A1 AQP9 CHRNA2 SLC1A7 RYR3 SLC9C1 CACNA1I CACNA1H | 1.27e-03 | 525 | 120 | 10 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | ASIC2 PKDREJ SLC1A1 AQP9 CHRNA2 SLC1A7 RYR3 SLC9C1 CACNA1I CACNA1H | 1.29e-03 | 526 | 120 | 10 | GO:0022803 |
| GeneOntologyMolecularFunction | antiporter activity | 1.48e-03 | 138 | 120 | 5 | GO:0015297 | |
| GeneOntologyMolecularFunction | L-aspartate transmembrane transporter activity | 1.56e-03 | 10 | 120 | 2 | GO:0015183 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | ASIC2 PKDREJ SLC1A1 CHRNA2 SLC1A7 RYR3 SLC9C1 CACNA1I CACNA1H | 1.83e-03 | 459 | 120 | 9 | GO:0005216 |
| GeneOntologyMolecularFunction | sulfur amino acid transmembrane transporter activity | 1.90e-03 | 11 | 120 | 2 | GO:0000099 | |
| GeneOntologyMolecularFunction | prostaglandin receptor activity | 1.90e-03 | 11 | 120 | 2 | GO:0004955 | |
| GeneOntologyMolecularFunction | symporter activity | 2.13e-03 | 150 | 120 | 5 | GO:0015293 | |
| GeneOntologyMolecularFunction | metal cation:monoatomic cation antiporter activity | 2.19e-03 | 43 | 120 | 3 | GO:0140828 | |
| GeneOntologyMolecularFunction | monoatomic anion transmembrane transporter activity | 2.20e-03 | 151 | 120 | 5 | GO:0008509 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 2.20e-03 | 151 | 120 | 5 | GO:0015085 | |
| GeneOntologyMolecularFunction | prostanoid receptor activity | 2.27e-03 | 12 | 120 | 2 | GO:0004954 | |
| GeneOntologyMolecularFunction | potassium:proton antiporter activity | 3.11e-03 | 14 | 120 | 2 | GO:0015386 | |
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 3.11e-03 | 14 | 120 | 2 | GO:0008331 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 3.57e-03 | 51 | 120 | 3 | GO:0140303 | |
| GeneOntologyMolecularFunction | C4-dicarboxylate transmembrane transporter activity | 3.57e-03 | 15 | 120 | 2 | GO:0015556 | |
| GeneOntologyMolecularFunction | sodium channel activity | 3.77e-03 | 52 | 120 | 3 | GO:0005272 | |
| GeneOntologyMolecularFunction | sodium:proton antiporter activity | 4.07e-03 | 16 | 120 | 2 | GO:0015385 | |
| GeneOntologyMolecularFunction | floppase activity | 4.07e-03 | 16 | 120 | 2 | GO:0140328 | |
| GeneOntologyMolecularFunction | icosanoid receptor activity | 4.07e-03 | 16 | 120 | 2 | GO:0004953 | |
| GeneOntologyMolecularFunction | solute:potassium antiporter activity | 5.73e-03 | 19 | 120 | 2 | GO:0022821 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DSCAM PCDHGA2 FAT3 PCDHB15 MCAM PCDHA13 CDH23 PCDHA8 PCDHA6 MAGI2 HMCN1 PCDH15 RIC8A | 2.95e-08 | 313 | 118 | 13 | GO:0098742 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DSCAM PCDHGA2 FAT3 PCDHB15 PCDHA13 CDH23 PCDHA8 PCDHA6 HMCN1 PCDH15 | 1.23e-07 | 187 | 118 | 10 | GO:0007156 |
| GeneOntologyBiologicalProcess | neutral amino acid transport | 1.20e-06 | 60 | 118 | 6 | GO:0015804 | |
| GeneOntologyBiologicalProcess | L-aspartate import across plasma membrane | 3.61e-06 | 6 | 118 | 3 | GO:0140009 | |
| GeneOntologyBiologicalProcess | retina layer formation | 1.17e-05 | 25 | 118 | 4 | GO:0010842 | |
| GeneOntologyBiologicalProcess | sodium ion transmembrane transport | 2.65e-05 | 208 | 118 | 8 | GO:0035725 | |
| GeneOntologyBiologicalProcess | L-aspartate transmembrane transport | 2.91e-05 | 11 | 118 | 3 | GO:0070778 | |
| GeneOntologyBiologicalProcess | negative regulation of deoxyribonuclease activity | 3.25e-05 | 2 | 118 | 2 | GO:0032076 | |
| GeneOntologyBiologicalProcess | righting reflex | 3.87e-05 | 12 | 118 | 3 | GO:0060013 | |
| GeneOntologyBiologicalProcess | L-glutamate transmembrane transport | 4.65e-05 | 35 | 118 | 4 | GO:0015813 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 5.40e-05 | 230 | 118 | 8 | GO:0098739 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 6.63e-05 | 120 | 118 | 6 | GO:0003333 | |
| GeneOntologyBiologicalProcess | cellular response to alkaloid | 7.93e-05 | 40 | 118 | 4 | GO:0071312 | |
| GeneOntologyBiologicalProcess | response to mechanical stimulus | 8.89e-05 | 247 | 118 | 8 | GO:0009612 | |
| GeneOntologyBiologicalProcess | regulation of eating behavior | 9.68e-05 | 16 | 118 | 3 | GO:1903998 | |
| GeneOntologyBiologicalProcess | cysteine transmembrane transport | 9.70e-05 | 3 | 118 | 2 | GO:1903712 | |
| GeneOntologyBiologicalProcess | L-glutamate import | 1.38e-04 | 46 | 118 | 4 | GO:0051938 | |
| GeneOntologyBiologicalProcess | fatty acid homeostasis | 1.40e-04 | 18 | 118 | 3 | GO:0055089 | |
| GeneOntologyBiologicalProcess | L-alpha-amino acid transmembrane transport | 1.43e-04 | 87 | 118 | 5 | GO:1902475 | |
| GeneOntologyBiologicalProcess | L-glutamate import across plasma membrane | 1.65e-04 | 19 | 118 | 3 | GO:0098712 | |
| GeneOntologyBiologicalProcess | sodium ion transport | 1.86e-04 | 275 | 118 | 8 | GO:0006814 | |
| GeneOntologyBiologicalProcess | cysteine transport | 1.93e-04 | 4 | 118 | 2 | GO:0042883 | |
| GeneOntologyBiologicalProcess | nonribosomal peptide biosynthetic process | 2.60e-04 | 22 | 118 | 3 | GO:0019184 | |
| GeneOntologyBiologicalProcess | aspartate transmembrane transport | 2.60e-04 | 22 | 118 | 3 | GO:0015810 | |
| GeneOntologyBiologicalProcess | eating behavior | 2.97e-04 | 56 | 118 | 4 | GO:0042755 | |
| GeneOntologyBiologicalProcess | L-amino acid transport | 3.92e-04 | 108 | 118 | 5 | GO:0015807 | |
| GeneOntologyBiologicalProcess | import into cell | DOCK1 APOC1 PTGER3 SLC1A1 LRP1B SLC1A2 SLC1A6 SLC1A7 LEPR MAGI2 SLC8A2 SLC9C1 SLC9A3 CACNA1I CACNA1H HEATR5B | 4.09e-04 | 1074 | 118 | 16 | GO:0098657 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | DSCAM PCDHGA2 FAT3 PCDHB15 MCAM PCDHA13 CDH23 PCDHA8 PCDHA6 GPAM MAGI2 HMCN1 TJP1 PCDH15 ADAMTS18 RIC8A | 4.22e-04 | 1077 | 118 | 16 | GO:0098609 |
| GeneOntologyBiologicalProcess | regulation of adenylate cyclase-activating G protein-coupled receptor signaling pathway | 4.31e-04 | 26 | 118 | 3 | GO:0106070 | |
| GeneOntologyBiologicalProcess | D-aspartate import across plasma membrane | 4.80e-04 | 6 | 118 | 2 | GO:0070779 | |
| GeneOntologyBiologicalProcess | D-aspartate transmembrane transport | 4.80e-04 | 6 | 118 | 2 | GO:0070777 | |
| GeneOntologyBiologicalProcess | positive regulation of actin filament-based movement | 4.80e-04 | 6 | 118 | 2 | GO:1903116 | |
| GeneOntologyBiologicalProcess | behavior | DSCAM ATP8A2 CDH23 PTGER3 PTGER4 SLC1A1 SLC1A2 LEPR SLC8A2 TTC21B PCDH15 RIC8A DGAT1 SEZ6L | 5.73e-04 | 891 | 118 | 14 | GO:0007610 |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 5.97e-04 | 180 | 118 | 6 | GO:0120254 | |
| GeneOntologyBiologicalProcess | C4-dicarboxylate transport | 5.98e-04 | 29 | 118 | 3 | GO:0015740 | |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC6A18 ASIC2 PTGER3 PKDREJ SLC1A1 SLC1A2 CHRNA2 SLC1A7 RYR3 SLC41A2 SLC8A2 SLC9C1 SLC9A3 CACNA1I CACNA1H UTRN | 6.15e-04 | 1115 | 118 | 16 | GO:0034220 |
| GeneOntologyBiologicalProcess | negative regulation of nuclease activity | 6.69e-04 | 7 | 118 | 2 | GO:0032074 | |
| GeneOntologyBiologicalProcess | negative regulation of eating behavior | 6.69e-04 | 7 | 118 | 2 | GO:1903999 | |
| GeneOntologyBiologicalProcess | reflex | 7.30e-04 | 31 | 118 | 3 | GO:0060004 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | SLC6A18 ASIC2 CDH23 PTGER3 PKDREJ SLC1A1 SLC1A2 SLC1A6 CHRNA2 SLC1A7 RYR3 SLC41A2 SLC8A2 SLC9C1 SLC9A3 CACNA1I CACNA1H UTRN | 8.02e-04 | 1374 | 118 | 18 | GO:0006811 |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 8.08e-04 | 343 | 118 | 8 | GO:0090596 | |
| GeneOntologyBiologicalProcess | regulation of behavior | 8.51e-04 | 128 | 118 | 5 | GO:0050795 | |
| GeneOntologyBiologicalProcess | circadian sleep/wake cycle, wakefulness | 8.88e-04 | 8 | 118 | 2 | GO:0042746 | |
| GeneOntologyBiologicalProcess | regulation of circadian sleep/wake cycle, wakefulness | 8.88e-04 | 8 | 118 | 2 | GO:0010840 | |
| GeneOntologyBiologicalProcess | D-amino acid transport | 8.88e-04 | 8 | 118 | 2 | GO:0042940 | |
| GeneOntologyBiologicalProcess | detection of mechanical stimulus | 9.05e-04 | 75 | 118 | 4 | GO:0050982 | |
| GeneOntologyBiologicalProcess | amino acid transport | 9.07e-04 | 195 | 118 | 6 | GO:0006865 | |
| Domain | NA_DICARBOXYL_SYMP_1 | 5.78e-08 | 7 | 121 | 4 | PS00713 | |
| Domain | NA_DICARBOXYL_SYMP_2 | 5.78e-08 | 7 | 121 | 4 | PS00714 | |
| Domain | SDF | 5.78e-08 | 7 | 121 | 4 | PF00375 | |
| Domain | - | 5.78e-08 | 7 | 121 | 4 | 1.10.3860.10 | |
| Domain | Na-dicarboxylate_symporter | 5.78e-08 | 7 | 121 | 4 | IPR001991 | |
| Domain | Na-dicarboxylate_symporter_CS | 5.78e-08 | 7 | 121 | 4 | IPR018107 | |
| Domain | Cadherin_CS | 5.41e-07 | 109 | 121 | 8 | IPR020894 | |
| Domain | CADHERIN_1 | 7.13e-07 | 113 | 121 | 8 | PS00232 | |
| Domain | Cadherin | 7.13e-07 | 113 | 121 | 8 | PF00028 | |
| Domain | CADHERIN_2 | 7.63e-07 | 114 | 121 | 8 | PS50268 | |
| Domain | - | 7.63e-07 | 114 | 121 | 8 | 2.60.40.60 | |
| Domain | CA | 8.15e-07 | 115 | 121 | 8 | SM00112 | |
| Domain | Cadherin-like | 8.71e-07 | 116 | 121 | 8 | IPR015919 | |
| Domain | Cadherin | 9.92e-07 | 118 | 121 | 8 | IPR002126 | |
| Domain | LRRC37AB_C | 1.06e-06 | 4 | 121 | 3 | IPR029423 | |
| Domain | LRRC37AB_C | 1.06e-06 | 4 | 121 | 3 | PF14914 | |
| Domain | LRRC37_N | 1.06e-06 | 4 | 121 | 3 | IPR032754 | |
| Domain | LRRC37 | 1.06e-06 | 4 | 121 | 3 | PF15779 | |
| Domain | LRRC37A/B-like | 1.06e-06 | 4 | 121 | 3 | IPR015753 | |
| Domain | EGF_CA | 4.48e-05 | 99 | 121 | 6 | PS01187 | |
| Domain | ASX_HYDROXYL | 4.74e-05 | 100 | 121 | 6 | PS00010 | |
| Domain | Cadherin_2 | 6.36e-05 | 65 | 121 | 5 | PF08266 | |
| Domain | Cadherin_N | 6.36e-05 | 65 | 121 | 5 | IPR013164 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 6.57e-05 | 106 | 121 | 6 | IPR000152 | |
| Domain | ARM-type_fold | 7.24e-05 | 339 | 121 | 10 | IPR016024 | |
| Domain | Cadherin_tail | 9.38e-05 | 37 | 121 | 4 | PF15974 | |
| Domain | Cadherin_CBD | 9.38e-05 | 37 | 121 | 4 | IPR031904 | |
| Domain | VDCC_T_a1 | 1.24e-04 | 3 | 121 | 2 | IPR005445 | |
| Domain | Prostglndn_DP_rcpt | 1.24e-04 | 3 | 121 | 2 | IPR001244 | |
| Domain | EGF-like_Ca-bd_dom | 1.56e-04 | 124 | 121 | 6 | IPR001881 | |
| Domain | EGF_CA | 2.41e-04 | 86 | 121 | 5 | PF07645 | |
| Domain | TMEM132D_N | 4.11e-04 | 5 | 121 | 2 | PF15705 | |
| Domain | TMEM132D_C | 4.11e-04 | 5 | 121 | 2 | PF15706 | |
| Domain | TMEM132_M | 4.11e-04 | 5 | 121 | 2 | IPR031437 | |
| Domain | TMEM132_C | 4.11e-04 | 5 | 121 | 2 | IPR031436 | |
| Domain | TMEM132_N | 4.11e-04 | 5 | 121 | 2 | IPR031435 | |
| Domain | TMEM132 | 4.11e-04 | 5 | 121 | 2 | IPR026307 | |
| Domain | TMEM132 | 4.11e-04 | 5 | 121 | 2 | PF16070 | |
| Domain | EGF_Ca-bd_CS | 4.21e-04 | 97 | 121 | 5 | IPR018097 | |
| Domain | ITI_HC_C | 6.14e-04 | 6 | 121 | 2 | IPR010600 | |
| Domain | ITI_HC_C | 6.14e-04 | 6 | 121 | 2 | PF06668 | |
| Domain | VIT | 1.14e-03 | 8 | 121 | 2 | PF08487 | |
| Domain | Prostanoid_rcpt | 1.14e-03 | 8 | 121 | 2 | IPR008365 | |
| Domain | VIT | 1.14e-03 | 8 | 121 | 2 | SM00609 | |
| Domain | EGF_CA | 1.19e-03 | 122 | 121 | 5 | SM00179 | |
| Domain | - | 1.36e-03 | 74 | 121 | 4 | 3.40.50.410 | |
| Domain | DNA/RNA_helicase_DEAH_CS | 1.49e-03 | 35 | 121 | 3 | IPR002464 | |
| Domain | GBP_C | 1.81e-03 | 10 | 121 | 2 | PF02841 | |
| Domain | VIT | 1.81e-03 | 10 | 121 | 2 | PS51468 | |
| Domain | VIT | 1.81e-03 | 10 | 121 | 2 | IPR013694 | |
| Domain | VDCCAlpha1 | 1.81e-03 | 10 | 121 | 2 | IPR002077 | |
| Domain | DEAH_ATP_HELICASE | 1.90e-03 | 38 | 121 | 3 | PS00690 | |
| Domain | VWFA | 1.99e-03 | 82 | 121 | 4 | PS50234 | |
| Domain | VWA | 2.17e-03 | 84 | 121 | 4 | SM00327 | |
| Domain | G_GB1_RHD3_dom | 2.20e-03 | 11 | 121 | 2 | IPR030386 | |
| Domain | Guanylate-bd_N | 2.20e-03 | 11 | 121 | 2 | IPR015894 | |
| Domain | Guanylate-bd_C | 2.20e-03 | 11 | 121 | 2 | IPR003191 | |
| Domain | GBP | 2.20e-03 | 11 | 121 | 2 | PF02263 | |
| Domain | Cation/H_exchanger_CPA1 | 2.20e-03 | 11 | 121 | 2 | IPR018422 | |
| Domain | G_GB1_RHD3 | 2.20e-03 | 11 | 121 | 2 | PS51715 | |
| Domain | - | 3.26e-03 | 222 | 121 | 6 | 1.25.10.10 | |
| Domain | EamA | 3.60e-03 | 14 | 121 | 2 | PF00892 | |
| Domain | P_typ_ATPase_c | 3.60e-03 | 14 | 121 | 2 | IPR032630 | |
| Domain | P-type_ATPase_N | 3.60e-03 | 14 | 121 | 2 | IPR032631 | |
| Domain | P-type_ATPase_IV | 3.60e-03 | 14 | 121 | 2 | IPR006539 | |
| Domain | Na_H_Exchanger | 3.60e-03 | 14 | 121 | 2 | PF00999 | |
| Domain | EamA_dom | 3.60e-03 | 14 | 121 | 2 | IPR000620 | |
| Domain | Cation/H_exchanger | 3.60e-03 | 14 | 121 | 2 | IPR006153 | |
| Domain | PhoLip_ATPase_C | 3.60e-03 | 14 | 121 | 2 | PF16212 | |
| Domain | PhoLip_ATPase_N | 3.60e-03 | 14 | 121 | 2 | PF16209 | |
| Domain | VWF_A | 3.93e-03 | 99 | 121 | 4 | IPR002035 | |
| Domain | EGF | 4.30e-03 | 235 | 121 | 6 | SM00181 | |
| Domain | EGF_3 | 4.30e-03 | 235 | 121 | 6 | PS50026 | |
| Domain | EGF-like_dom | 5.68e-03 | 249 | 121 | 6 | IPR000742 | |
| Domain | VWA | 5.73e-03 | 56 | 121 | 3 | PF00092 | |
| Domain | Ion_trans_dom | 6.47e-03 | 114 | 121 | 4 | IPR005821 | |
| Domain | Ion_trans | 6.47e-03 | 114 | 121 | 4 | PF00520 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.53e-07 | 108 | 88 | 8 | M823 | |
| Pathway | REACTOME_TRANSPORT_OF_INORGANIC_CATIONS_ANIONS_AND_AMINO_ACIDS_OLIGOPEPTIDES | 3.79e-07 | 109 | 88 | 8 | MM15074 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC6A18 ATP8B3 ASIC2 ATP8A2 APOC1 SLC7A6 SLC1A1 SLC1A2 AQP9 SLC1A6 SLC1A7 RYR3 SLC41A2 SLC8A2 SLC9C1 SLC9A3 | 1.10e-05 | 736 | 88 | 16 | M27287 |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 1.37e-05 | 24 | 88 | 4 | MM14834 | |
| Pathway | REACTOME_GLUTAMATE_NEUROTRANSMITTER_RELEASE_CYCLE | 1.37e-05 | 24 | 88 | 4 | M630 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC6A18 SLC7A6 SLC1A1 SLC1A2 SLC1A6 SLC1A7 SLC41A2 SLC8A2 SLC9A3 | 1.72e-05 | 238 | 88 | 9 | MM15076 |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC6A18 ATP8B3 ASIC2 ATP8A2 APOC1 SLC7A6 SLC1A1 SLC1A2 AQP9 SLC1A6 SLC1A7 RYR3 SLC41A2 SLC8A2 SLC9A3 | 1.85e-05 | 681 | 88 | 15 | MM14985 |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | SLC6A18 SLC7A6 SLC1A1 SLC1A2 SLC1A6 SLC1A7 SLC41A2 SLC8A2 SLC9A3 | 2.46e-05 | 249 | 88 | 9 | M5988 |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 2.83e-04 | 51 | 88 | 4 | M4281 | |
| Pathway | REACTOME_NEUROTRANSMITTER_RELEASE_CYCLE | 2.83e-04 | 51 | 88 | 4 | MM14499 | |
| Pathway | REACTOME_METHIONINE_SALVAGE_PATHWAY | 5.69e-04 | 6 | 88 | 2 | M26927 | |
| Pubmed | 1.94e-07 | 4 | 128 | 3 | 16600856 | ||
| Pubmed | 1.94e-07 | 4 | 128 | 3 | 9379843 | ||
| Pubmed | 1.94e-07 | 4 | 128 | 3 | 22419166 | ||
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 2.51e-07 | 171 | 128 | 8 | 20201926 | |
| Pubmed | 4.84e-07 | 5 | 128 | 3 | 9129177 | ||
| Pubmed | 1.76e-06 | 24 | 128 | 4 | 24698270 | ||
| Pubmed | Two quantitative trait loci affecting progressive hearing loss in 101/H mice. | 2.69e-06 | 8 | 128 | 3 | 16897347 | |
| Pubmed | Comparative DNA sequence analysis of mouse and human protocadherin gene clusters. | 5.40e-06 | 68 | 128 | 5 | 11230163 | |
| Pubmed | 5.73e-06 | 10 | 128 | 3 | 23064749 | ||
| Pubmed | 6.34e-06 | 187 | 128 | 7 | 26460568 | ||
| Pubmed | A striking organization of a large family of human neural cadherin-like cell adhesion genes. | 7.17e-06 | 72 | 128 | 5 | 10380929 | |
| Pubmed | Diversity revealed by a novel family of cadherins expressed in neurons at a synaptic complex. | 7.86e-06 | 11 | 128 | 3 | 9655502 | |
| Pubmed | Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. | 8.20e-06 | 74 | 128 | 5 | 10817752 | |
| Pubmed | 9.97e-06 | 77 | 128 | 5 | 10835267 | ||
| Pubmed | Proteins of the CNR family are multiple receptors for Reelin. | 1.05e-05 | 12 | 128 | 3 | 10612399 | |
| Pubmed | Systematic protein-protein interaction mapping for clinically relevant human GPCRs. | JKAMP PTGER4 CLPTM1L SLC8A2 DST GBP5 SACS INF2 DHRS7 CACNA1H GOT1 DGAT1 | 1.09e-05 | 697 | 128 | 12 | 28298427 |
| Pubmed | Large exons encoding multiple ectodomains are a characteristic feature of protocadherin genes. | 1.20e-05 | 80 | 128 | 5 | 10716726 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 37302692 | ||
| Pubmed | A T-type calcium channel required for normal function of a mammalian mechanoreceptor. | 1.34e-05 | 2 | 128 | 2 | 12808460 | |
| Pubmed | Molecular cloning of two glutamate transporter subtypes from mouse brain. | 1.34e-05 | 2 | 128 | 2 | 7766664 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 25071191 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 15290741 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 36786913 | ||
| Pubmed | Structure of a force-conveying cadherin bond essential for inner-ear mechanotransduction. | 1.34e-05 | 2 | 128 | 2 | 23135401 | |
| Pubmed | Using thermal scanning assays to test protein-protein interactions of inner-ear cadherins. | 1.34e-05 | 2 | 128 | 2 | 29261728 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 15528329 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 23364535 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 19270079 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 21940737 | ||
| Pubmed | Defective glycerol metabolism in aquaporin 9 (AQP9) knockout mice. | 1.34e-05 | 2 | 128 | 2 | 17360690 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 20503412 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 15537665 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 17360917 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 35069585 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 21311040 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 15187084 | ||
| Pubmed | The deleterious role of the prostaglandin E2 EP3 receptor in angiotensin II hypertension. | 1.34e-05 | 2 | 128 | 2 | 32142358 | |
| Pubmed | Antitumor immunity and prognosis value elicited by FAT3 and LRP1B co-mutation in endometrial cancer. | 1.34e-05 | 2 | 128 | 2 | 38696842 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 27711210 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 22615395 | ||
| Pubmed | Glutamate transporters EAAT4 and EAAT5 are expressed in vestibular hair cells and calyx endings. | 1.34e-05 | 2 | 128 | 2 | 23049999 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 32835555 | ||
| Pubmed | Double homozygous waltzer and Ames waltzer mice provide no evidence of retinal degeneration. | 1.34e-05 | 2 | 128 | 2 | 19057657 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 34626853 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 26416971 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 21532990 | ||
| Pubmed | Functional properties of the retinal glutamate transporters GLT-1c and EAAT5. | 1.34e-05 | 2 | 128 | 2 | 24307171 | |
| Pubmed | Intron-less processed Pcdhalpha genes in the central nervous system. | 1.34e-05 | 2 | 128 | 2 | 14697259 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 12637575 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 21424266 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 20739546 | ||
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 23451239 | ||
| Pubmed | ZO-1 expression and phosphorylation in diabetic nephropathy. | 1.34e-05 | 2 | 128 | 2 | 16567508 | |
| Pubmed | The Prostaglandin E2 Receptor EP4 Regulates Obesity-Related Inflammation and Insulin Sensitivity. | 1.34e-05 | 2 | 128 | 2 | 26308623 | |
| Pubmed | The glutamate transporters EAAT2 and EAAT3 mediate cysteine uptake in cortical neuron cultures. | 1.34e-05 | 2 | 128 | 2 | 12614333 | |
| Pubmed | 1.34e-05 | 2 | 128 | 2 | 27046121 | ||
| Pubmed | 2.14e-05 | 15 | 128 | 3 | 15640798 | ||
| Pubmed | 3.19e-05 | 17 | 128 | 3 | 29911975 | ||
| Pubmed | 3.75e-05 | 167 | 128 | 6 | 22159717 | ||
| Pubmed | CNR/Pcdhalpha family in subplate neurons, and developing cortical connectivity. | 3.82e-05 | 18 | 128 | 3 | 15570159 | |
| Pubmed | Genomic organization of the family of CNR cadherin genes in mice and humans. | 3.82e-05 | 18 | 128 | 3 | 10662547 | |
| Pubmed | The potential role of glutamate transporters in the pathogenesis of normal tension glaucoma. | 4.02e-05 | 3 | 128 | 2 | 17607354 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 9124591 | ||
| Pubmed | Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C. | 4.02e-05 | 3 | 128 | 2 | 23488970 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 35523583 | ||
| Pubmed | Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart. | 4.02e-05 | 3 | 128 | 2 | 11230107 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 12401709 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 33547341 | ||
| Pubmed | Calmodulin regulates Cav3 T-type channels at their gating brake. | 4.02e-05 | 3 | 128 | 2 | 28972185 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 32585762 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 27208619 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 17540780 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 27978527 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 11897840 | ||
| Pubmed | Climbing fiber activation of EAAT4 transporters and kainate receptors in cerebellar Purkinje cells. | 4.02e-05 | 3 | 128 | 2 | 14715943 | |
| Pubmed | A real-time PCR signature to discriminate between tuberculosis and other pulmonary diseases. | 4.02e-05 | 3 | 128 | 2 | 26025597 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 29679339 | ||
| Pubmed | Increased expression and function of glutamate transporters in multiple sclerosis. | 4.02e-05 | 3 | 128 | 2 | 16061389 | |
| Pubmed | Mapping quantitative trait loci for hearing loss in Black Swiss mice. | 4.02e-05 | 3 | 128 | 2 | 16426780 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 26488564 | ||
| Pubmed | Differential interactions of Na+ channel toxins with T-type Ca2+ channels. | 4.02e-05 | 3 | 128 | 2 | 18591418 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 27037668 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 16679490 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 28846697 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 22215633 | ||
| Pubmed | Distribution of glutamate transporters in the human placenta. | 4.02e-05 | 3 | 128 | 2 | 15135231 | |
| Pubmed | Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. | 4.02e-05 | 3 | 128 | 2 | 7521911 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 11927664 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 9348184 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 17727989 | ||
| Pubmed | Multiple roles of the PGE2 -EP receptor signal in vascular permeability. | 4.02e-05 | 3 | 128 | 2 | 24923772 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 32640908 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 15928608 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 16760259 | ||
| Pubmed | Dynamic changes in expression of glutamate transporter mRNAs in developing brain. | 4.02e-05 | 3 | 128 | 2 | 8733726 | |
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 17221839 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 20220082 | ||
| Pubmed | 4.02e-05 | 3 | 128 | 2 | 20498078 | ||
| Pubmed | Inositol 1,4,5-trisphosphate signaling maintains the activity of glutamate uptake in Bergmann glia. | 4.02e-05 | 3 | 128 | 2 | 20958799 | |
| Pubmed | CircDOCK1 suppresses cell apoptosis via inhibition of miR‑196a‑5p by targeting BIRC3 in OSCC. | 4.02e-05 | 3 | 128 | 2 | 29286141 | |
| Cytoband | 5q31 | 1.87e-05 | 115 | 128 | 5 | 5q31 | |
| Cytoband | 15q13 | 2.74e-04 | 9 | 128 | 2 | 15q13 | |
| Cytoband | 12q13.2 | 5.00e-04 | 55 | 128 | 3 | 12q13.2 | |
| GeneFamily | Solute carriers | SLC6A18 SLC35E1 SLC7A6 SLC1A1 SLC1A2 SLC1A6 SLC1A7 SLC35F5 SLC41A2 SLC8A2 SLC9C1 SLC9A3 | 2.40e-07 | 395 | 83 | 12 | 752 |
| GeneFamily | Clustered protocadherins | 1.11e-05 | 64 | 83 | 5 | 20 | |
| GeneFamily | Cadherin related | 6.06e-05 | 17 | 83 | 3 | 24 | |
| GeneFamily | Prostaglandin (prostanoid) receptors | 7.34e-04 | 9 | 83 | 2 | 207 | |
| GeneFamily | Actins|Deafness associated genes | 1.82e-03 | 113 | 83 | 4 | 1152 | |
| GeneFamily | ATPase phospholipid transporting | 2.10e-03 | 15 | 83 | 2 | 1210 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.63e-10 | 160 | 128 | 9 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.63e-10 | 160 | 128 | 9 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-08 | 184 | 128 | 8 | 2cbed6462fea2622871bb7e49b0df3d984239281 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-08 | 184 | 128 | 8 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.32e-08 | 184 | 128 | 8 | 2b19a8c5f823e00812908b23e66bb4e563278aff | |
| ToppCell | RA-10._Endothelium_II|World / Chamber and Cluster_Paper | 7.77e-08 | 189 | 128 | 8 | 75c248b9de5e2fb7a0baa8cdbab516e575cc4394 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.09e-08 | 190 | 128 | 8 | 6c7e1086c0a274cd5527c3104106e372811c9905 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 9.13e-08 | 193 | 128 | 8 | b3ad5ff480d99217f36cc7471e5a96a519ddb409 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.50e-08 | 194 | 128 | 8 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.16e-07 | 199 | 128 | 8 | 333056c2abe9724efeab542c0365fcfe4eff8f18 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.16e-07 | 199 | 128 | 8 | 19a97e27a4758e794ce7246d295e112b47931a48 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.16e-07 | 199 | 128 | 8 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.52e-07 | 162 | 128 | 7 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-07 | 169 | 128 | 7 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | normal_Lymph_Node-Myeloid_cells-pDCs|Myeloid_cells / Location, Cell class and cell subclass | 7.31e-07 | 174 | 128 | 7 | 2274648b80dd74f3c948a779bba3391095964c34 | |
| ToppCell | COVID-19-kidney-Podocyte|kidney / Disease (COVID-19 only), tissue and cell type | 1.03e-06 | 183 | 128 | 7 | fb5e2a31b560126e1c04a386c24c365901c60ad7 | |
| ToppCell | droplet-Heart-4Chambers-21m-Endothelial-leukocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.10e-06 | 185 | 128 | 7 | bb5a4cf93534b9bcd0923f314c389d571e91e7f8 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.27e-06 | 189 | 128 | 7 | 203c80030df08ae112f9ae4043709f455d87ce89 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 1.27e-06 | 189 | 128 | 7 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 1.41e-06 | 192 | 128 | 7 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 1.46e-06 | 193 | 128 | 7 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.46e-06 | 193 | 128 | 7 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 1.46e-06 | 193 | 128 | 7 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.51e-06 | 194 | 128 | 7 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 1.57e-06 | 195 | 128 | 7 | 0e55fa5b3cbeb7baee3d4ac272a3bf80381ec937 | |
| ToppCell | facs-Thymus-Thymus_Epithelium|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 196 | 128 | 7 | 6bc1187dfc4860a4e09032d7ea87ba3d9fe9f363 | |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.62e-06 | 196 | 128 | 7 | c8c89e469402e11aa2a9561e859b6fd1fb66c39b | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.62e-06 | 196 | 128 | 7 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 1.73e-06 | 198 | 128 | 7 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | distal-Endothelial-Vein-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.85e-06 | 200 | 128 | 7 | ff88d28162e0231d5dac0e0c6bec98fa8da58a23 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC-E|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 5.82e-06 | 155 | 128 | 6 | 77fdae85d36efb776db977eb424b32487ef222e4 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.87e-06 | 170 | 128 | 6 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | COVID-19-kidney-PCT-S3-2|kidney / Disease (COVID-19 only), tissue and cell type | 1.13e-05 | 174 | 128 | 6 | 5aa2fb631505600f37d2b87b02def7be139dc262 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-05 | 177 | 128 | 6 | 8220cc2fc0ee8764a67a3be51d75248be2453040 | |
| ToppCell | 356C-Fibroblasts-Fibroblast-G-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.24e-05 | 177 | 128 | 6 | 7617270f49cd6b7ba66db72d20560cee985012b2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.28e-05 | 178 | 128 | 6 | edc7143dc9959d36057cb9471681a23afcbc8cce | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-05 | 181 | 128 | 6 | 5bf7aa43f6e6ecce15c95928b91195544d6928c4 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.41e-05 | 181 | 128 | 6 | 8e751f5d7cd2d328ec0196d874e8a507e8c4e1a9 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-05 | 182 | 128 | 6 | 3cc61f5f7ad4a81eba3daf65e122880b5af3adc0 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Non-neuronal-Macroglial-Oligo-OPC-OPC_L1-6_MYT1|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.45e-05 | 182 | 128 | 6 | 5d909e4b5f662905bf1be9c686bbddc3e87d2be9 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 183 | 128 | 6 | 3c516fe5083f02bad1f464ed284010b4131a833c | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 183 | 128 | 6 | 612d93df03252d4d2ccdce5a9bc162cfd9172a1a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 183 | 128 | 6 | eb559ae3ae252d9365c24ef557dd49b78ed6d898 | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 183 | 128 | 6 | 9c2689d76fc6d30f5ab093428aa669d0a98953cf | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.50e-05 | 183 | 128 | 6 | 7c4b775f351794a3de06bd503eecbc8ae8577c44 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.55e-05 | 184 | 128 | 6 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.55e-05 | 184 | 128 | 6 | 7294b379ce4cb8fa75e432559082f93cd106aaf5 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.55e-05 | 184 | 128 | 6 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.59e-05 | 185 | 128 | 6 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | droplet-Heart-nan-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 186 | 128 | 6 | 0ae5fbe9f210cb25092394267e1d3d6ed05627b8 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.64e-05 | 186 | 128 | 6 | 5302399825f213d105ac70b91366a4513b732838 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 1.69e-05 | 187 | 128 | 6 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 1.69e-05 | 187 | 128 | 6 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | pdx-Tumor_cells-T5|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells) | 1.69e-05 | 187 | 128 | 6 | 7e376831a11ee72ed87abcdac631ca46ae29c250 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-glomerular_visceral_epithelial_cell-Podocyte|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.69e-05 | 187 | 128 | 6 | 24c2a3962da364e46e98abeab5f8234376fa26bb | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 1.69e-05 | 187 | 128 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.75e-05 | 188 | 128 | 6 | 3177b2c1723268d330d3e9f24f9e24492ace6286 | |
| ToppCell | ILEUM-inflamed-(1)_Cytotoxic_CD8_Trm|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.75e-05 | 188 | 128 | 6 | d26894d1066a70e4b32ae41fff1c4718f2591ba9 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.80e-05 | 189 | 128 | 6 | 7346c1112e2e155dbd71b6dbc80e680fd262a691 | |
| ToppCell | facs-Pancreas-Endocrine-3m-Epithelial-pancreatic_D_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-05 | 189 | 128 | 6 | fcc3713e8200d51074f709f3360fb36efb0a639f | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_1-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.85e-05 | 190 | 128 | 6 | 30b50d183d7649146eb1e79b47ba897355f1998a | |
| ToppCell | PND10|World / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.85e-05 | 190 | 128 | 6 | d67e2814047c8df2ae4b7bc8be9539f5df6ecef2 | |
| ToppCell | (5)_Fibroblasts-(5)_Fibroblast-C_(Myofibroblast)|(5)_Fibroblasts / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.85e-05 | 190 | 128 | 6 | 71e112dfb8c3190fe0286b45a046ea789eb6a8db | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 1.85e-05 | 190 | 128 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.91e-05 | 191 | 128 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.97e-05 | 192 | 128 | 6 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | control-Lymphoid-CTL|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.03e-05 | 193 | 128 | 6 | 89d407a88b5956559a589425b89b3eb8dc78e1dd | |
| ToppCell | nucseq-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-VEC|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.03e-05 | 193 | 128 | 6 | 9ba688b35a9ead5d04691b3f3f15484f02dbbd0d | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.03e-05 | 193 | 128 | 6 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.09e-05 | 194 | 128 | 6 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature5_(6)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.09e-05 | 194 | 128 | 6 | b1bb0f846d2865efdd9bc8842b16b9d069785882 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 2.09e-05 | 194 | 128 | 6 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.09e-05 | 194 | 128 | 6 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.09e-05 | 194 | 128 | 6 | 89b706af2b25991fc2707eb24f49ba6ff3ae01f7 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.09e-05 | 194 | 128 | 6 | 43eb677a76634bb9a48a40e0d607c4936ae64bcc | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.15e-05 | 195 | 128 | 6 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.15e-05 | 195 | 128 | 6 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 2.15e-05 | 195 | 128 | 6 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 3'-Child09-12|3' / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.21e-05 | 196 | 128 | 6 | 1bcc4ffff51cdb6211824686c2422c43b09e24b2 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-05 | 197 | 128 | 6 | 8d5097898dd01cedb04cb694cb480c931e08462c | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.27e-05 | 197 | 128 | 6 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.27e-05 | 197 | 128 | 6 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.27e-05 | 197 | 128 | 6 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.34e-05 | 198 | 128 | 6 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | ASK428-Epithelial-Type_1|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.34e-05 | 198 | 128 | 6 | 0047a9ef7684230ac5179efea94461480e90bdaf | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Bronchial_vessel|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.41e-05 | 199 | 128 | 6 | 53b6a661d381b1ed3ea96e61e8bd1750de7d9fda | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 2.41e-05 | 199 | 128 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Parenchyma_Control_(B.)-Endothelial-TX-Bronchial_vessel|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 2.41e-05 | 199 | 128 | 6 | 9c753043024871b1f1436fc39defac4da85e10cd | |
| ToppCell | Lung_Parenchyma-Control-Endothelial-Endothelial-Bronchial_vessel-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.41e-05 | 199 | 128 | 6 | d017dd91f9b10038f1f83753a766e534da2dbe89 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 2.47e-05 | 200 | 128 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA-|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.47e-05 | 200 | 128 | 6 | f17b5a54e8f9eba9dcd0808ba4e8d275ac41bce2 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA--|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.47e-05 | 200 | 128 | 6 | cc3409518f8b436ea92deb955e81114b3f410ff7 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.47e-05 | 200 | 128 | 6 | c24a3099e3d96d8b72f6d05286bb355d661a0377 | |
| ToppCell | Sepsis-ICU-NoSEP-Myeloid-cDC2|ICU-NoSEP / Disease, condition lineage and cell class | 2.47e-05 | 200 | 128 | 6 | 59cb0b0dee2599b3d3014b66d71d84c22b5de4b2 | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2-SCUBE1|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.47e-05 | 200 | 128 | 6 | 012dd2180f6f596d6e55e864be2e62b53c15edb2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.47e-05 | 200 | 128 | 6 | ad777683adeb2ce45ade570386235e311fa7ea2d | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-05 | 200 | 128 | 6 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | Macroglial-Polydendrocytes-PDGFRA---|Macroglial / cells hierarchy compared to all cells using T-Statistic | 2.47e-05 | 200 | 128 | 6 | 4fc3de4bff7ed2bf40b38462c4b4e9b87af6a4ca | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.47e-05 | 200 | 128 | 6 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Neuronal-Excitatory-eE(FEZF2_SLC17A7)-eE_2-SCUBE1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 2.47e-05 | 200 | 128 | 6 | 06f949c81eecba00203f0716d0c5854724871184 | |
| Drug | anthglutin | 5.58e-07 | 13 | 123 | 4 | CID000125748 | |
| Drug | sodium | SLC6A18 ATP8B3 ASIC2 ATP8A2 BIRC3 CCT4 SLC7A6 SLC1A1 SLC1A2 SLC1A6 CHRNA2 SLC1A7 RYR3 SLC8A2 SLC9A3 SACS TJP1 CACNA1H | 3.23e-06 | 944 | 123 | 18 | CID000000923 |
| Drug | AC1L1BIH | 5.30e-06 | 7 | 123 | 3 | CID000001453 | |
| Drug | Doxorubicin hydrochloride [25316-40-9]; Up 200; 6.8uM; PC3; HT_HG-U133A | 1.20e-05 | 197 | 123 | 8 | 4610_UP | |
| Drug | N-methyl-DL-aspartic acid | BIRC3 PDE10A PTGER3 PTGER4 SLC1A1 SLC1A2 CHRNA2 SLC1A7 ITIH4 RYR3 MAGI2 EIF4G2 CACNA1I CACNA1H | 1.25e-05 | 655 | 123 | 14 | CID000004376 |
| Drug | Heymann Nephritis Antigenic Complex | 2.89e-05 | 2 | 123 | 2 | ctd:D026541 | |
| Drug | L-Glutamic Acid | 3.37e-05 | 68 | 123 | 5 | DB00142 | |
| Drug | ethyldichloroarsine | 3.73e-05 | 35 | 123 | 4 | CID000011711 | |
| Drug | felodipine | 3.78e-05 | 169 | 123 | 7 | CID000003333 | |
| Drug | glycine | 3.78e-05 | 169 | 123 | 7 | CID000000750 | |
| Drug | hydride | ATP8B3 SP3 CYP4F8 CYP2F1 ASIC2 ATP8A2 GPAM APOC1 SLC1A1 SLC1A2 SLC1A6 SLC9A3 VCAN CACNA1I CACNA1H | 4.53e-05 | 835 | 123 | 15 | CID000000783 |
| Drug | allo-threonine | 4.64e-05 | 119 | 123 | 6 | CID000000205 | |
| Drug | AC1NSKAN | 5.36e-05 | 14 | 123 | 3 | CID005311244 | |
| Drug | hilE | 5.77e-05 | 76 | 123 | 5 | CID000000791 | |
| Drug | Ro106-9920 | 6.68e-05 | 15 | 123 | 3 | CID003906779 | |
| Drug | enzacamene | 7.28e-05 | 129 | 123 | 6 | ctd:C038939 | |
| Drug | ptaquiloside | 8.62e-05 | 133 | 123 | 6 | ctd:C043680 | |
| Drug | AC1NSX87 | 8.65e-05 | 3 | 123 | 2 | CID005318728 | |
| Drug | AC1L1H0W | 8.65e-05 | 3 | 123 | 2 | CID000003927 | |
| Drug | 1,3-dioxoisoindoline-5-carboxamide | 8.65e-05 | 3 | 123 | 2 | CID010679219 | |
| Drug | Misoprostol | 8.65e-05 | 3 | 123 | 2 | DB00929 | |
| Drug | SureCN2398996 | 8.65e-05 | 3 | 123 | 2 | CID010220069 | |
| Drug | N-desmethylmethsuximide | 8.65e-05 | 3 | 123 | 2 | CID000092154 | |
| Drug | Rapamycin; Up 200; 0.1uM; PC3; HT_HG-U133A | 8.75e-05 | 193 | 123 | 7 | 4431_UP | |
| Drug | creatine | 8.75e-05 | 193 | 123 | 7 | CID000000586 | |
| Drug | Dipyridamole [58-32-2]; Up 200; 8uM; MCF7; HT_HG-U133A | 9.33e-05 | 195 | 123 | 7 | 1517_UP | |
| Drug | rosiglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 9.63e-05 | 196 | 123 | 7 | 5230_UP | |
| Drug | Flunisolide [3385-03-3]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 9.63e-05 | 196 | 123 | 7 | 3923_UP | |
| Drug | AC1L1BXF | 9.85e-05 | 85 | 123 | 5 | CID000001650 | |
| Drug | Guanabenz acetate [23256-50-0]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 1.03e-04 | 198 | 123 | 7 | 1544_UP | |
| Drug | Flavoxate hydrochloride [3717-88-2]; Up 200; 9.4uM; MCF7; HT_HG-U133A | 1.03e-04 | 198 | 123 | 7 | 5427_UP | |
| Drug | ICI 182,780; Up 200; 1uM; HL60; HT_HG-U133A | 1.03e-04 | 198 | 123 | 7 | 6165_UP | |
| Drug | Troleandomycin [2751-09-9]; Up 200; 5uM; MCF7; HT_HG-U133A | 1.03e-04 | 198 | 123 | 7 | 1465_UP | |
| Drug | Solanine alpha [20562-02-1]; Up 200; 4.6uM; MCF7; HT_HG-U133A | 1.06e-04 | 199 | 123 | 7 | 4166_UP | |
| Drug | Mafenide hydrochloride [138-37-4]; Up 200; 18uM; PC3; HT_HG-U133A | 1.06e-04 | 199 | 123 | 7 | 5079_UP | |
| Drug | Norgestrel-(-)-D [797-63-7]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 1.06e-04 | 199 | 123 | 7 | 3606_UP | |
| Drug | Mepenzolate bromide [76-90-4]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 1.06e-04 | 199 | 123 | 7 | 6024_UP | |
| Drug | potassium | PDS5B ATP8B3 ASIC2 ATP8A2 SLC1A1 SLC1A2 SLC1A6 CHRNA2 SLC1A7 GSK3A RYR3 SLC8A2 SLC9A3 SACS CACNA1I CACNA1H | 1.07e-04 | 1008 | 123 | 16 | CID000000813 |
| Drug | (cis-) Nanophine [5072-45-7]; Up 200; 26.8uM; MCF7; HT_HG-U133A | 1.09e-04 | 200 | 123 | 7 | 6049_UP | |
| Drug | PF-01378883-00 [351320-41-7]; Down 200; 10uM; MCF7; HT_HG-U133A | 1.09e-04 | 200 | 123 | 7 | 6405_DN | |
| Drug | Xylazine [7361-61-7]; Up 200; 18.2uM; MCF7; HT_HG-U133A | 1.09e-04 | 200 | 123 | 7 | 2788_UP | |
| Drug | octylmethoxycinnamate | 1.10e-04 | 139 | 123 | 6 | ctd:C118580 | |
| Drug | beta-hydroxyaspartic acid | 1.21e-04 | 47 | 123 | 4 | CID000005425 | |
| Drug | 1,3,5-tris(4-hydroxyphenyl)-4-propyl-1H-pyrazole | 1.29e-04 | 90 | 123 | 5 | ctd:C419153 | |
| Disease | episodic ataxia type 6 (implicated_via_orthology) | 1.30e-06 | 6 | 120 | 3 | DOID:0050994 (implicated_via_orthology) | |
| Disease | Bipolar Disorder | DSCAM PDE10A ERVW-1 SLC1A1 SLC1A2 SLC1A6 CHRNA2 GSK3A ITIH4 MAGI2 SEZ6L | 4.19e-06 | 477 | 120 | 11 | C0005586 |
| Disease | Usher syndrome, type 1D | 1.64e-05 | 2 | 120 | 2 | C2931208 | |
| Disease | USHER SYNDROME, TYPE ID | 1.64e-05 | 2 | 120 | 2 | C1832845 | |
| Disease | USHER SYNDROME, TYPE ID | 1.64e-05 | 2 | 120 | 2 | 601067 | |
| Disease | Usher syndrome type 1D | 1.64e-05 | 2 | 120 | 2 | cv:C1832845 | |
| Disease | Usher syndrome type 1D (is_implicated_in) | 1.64e-05 | 2 | 120 | 2 | DOID:0110831 (is_implicated_in) | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 1.82e-05 | 13 | 120 | 3 | C1846647 | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 6.06e-05 | 19 | 120 | 3 | DOID:1591 (biomarker_via_orthology) | |
| Disease | Usher syndrome, type 1A | 1.63e-04 | 5 | 120 | 2 | C2931205 | |
| Disease | hereditary sensory neuropathy (implicated_via_orthology) | 1.63e-04 | 5 | 120 | 2 | DOID:0050548 (implicated_via_orthology) | |
| Disease | word list delayed recall measurement, memory performance, paragraph delayed recall measurement | 1.63e-04 | 5 | 120 | 2 | EFO_0004874, EFO_0006805, EFO_0006806 | |
| Disease | USHER SYNDROME, TYPE IB (disorder) | 1.63e-04 | 5 | 120 | 2 | C1848638 | |
| Disease | USHER SYNDROME, TYPE IA, FORMERLY | 1.63e-04 | 5 | 120 | 2 | C1848639 | |
| Disease | USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY | 1.63e-04 | 5 | 120 | 2 | C1848640 | |
| Disease | Usher syndrome type 1 | 1.63e-04 | 5 | 120 | 2 | cv:C1568247 | |
| Disease | 1,5 anhydroglucitol measurement | 2.22e-04 | 29 | 120 | 3 | EFO_0008009 | |
| Disease | Usher Syndrome, Type I | 2.43e-04 | 6 | 120 | 2 | C1568247 | |
| Disease | Epileptic encephalopathy | 2.46e-04 | 30 | 120 | 3 | C0543888 | |
| Disease | neutrophil count, basophil count | 3.18e-04 | 224 | 120 | 6 | EFO_0004833, EFO_0005090 | |
| Disease | neurodegenerative disease (implicated_via_orthology) | 3.24e-04 | 145 | 120 | 5 | DOID:1289 (implicated_via_orthology) | |
| Disease | Hereditary retinal dystrophy | 3.40e-04 | 7 | 120 | 2 | C0154860 | |
| Disease | Usher syndrome | 3.40e-04 | 7 | 120 | 2 | cv:C0271097 | |
| Disease | visceral adipose tissue measurement, body mass index | 4.46e-04 | 87 | 120 | 4 | EFO_0004340, EFO_0004765 | |
| Disease | pancreatic carcinoma | 7.43e-04 | 174 | 120 | 5 | EFO_0002618 | |
| Disease | interleukin 17 measurement | 8.22e-04 | 45 | 120 | 3 | EFO_0008174 | |
| Disease | Diarrhea | 8.81e-04 | 11 | 120 | 2 | C0011991 | |
| Disease | hepatocellular carcinoma (is_implicated_in) | 8.86e-04 | 181 | 120 | 5 | DOID:684 (is_implicated_in) | |
| Disease | lipoprotein measurement | 9.06e-04 | 105 | 120 | 4 | EFO_0004732 | |
| Disease | gallbladder carcinoma (is_marker_for) | 1.05e-03 | 12 | 120 | 2 | DOID:4948 (is_marker_for) | |
| Disease | Ciliopathies | 1.08e-03 | 110 | 120 | 4 | C4277690 | |
| Disease | Nonsyndromic Hearing Loss and Deafness, Autosomal Recessive | 1.18e-03 | 51 | 120 | 3 | cv:CN043650 | |
| Disease | free cholesterol measurement | 1.19e-03 | 113 | 120 | 4 | EFO_0008591 | |
| Disease | Drug habituation | 1.27e-03 | 115 | 120 | 4 | C0013170 | |
| Disease | Drug abuse | 1.27e-03 | 115 | 120 | 4 | C0013146 | |
| Disease | Prescription Drug Abuse | 1.27e-03 | 115 | 120 | 4 | C4316881 | |
| Disease | Substance-Related Disorders | 1.27e-03 | 115 | 120 | 4 | C0236969 | |
| Disease | Drug Use Disorders | 1.27e-03 | 115 | 120 | 4 | C0013222 | |
| Disease | Drug Dependence | 1.27e-03 | 115 | 120 | 4 | C1510472 | |
| Disease | Substance Dependence | 1.27e-03 | 115 | 120 | 4 | C0038580 | |
| Disease | Substance Use Disorders | 1.27e-03 | 115 | 120 | 4 | C0038586 | |
| Disease | Organic Mental Disorders, Substance-Induced | 1.27e-03 | 115 | 120 | 4 | C0029231 | |
| Disease | Substance abuse problem | 1.31e-03 | 116 | 120 | 4 | C0740858 | |
| Disease | Pneumoconiosis | 1.45e-03 | 14 | 120 | 2 | C0032273 | |
| Disease | Bagassosis | 1.45e-03 | 14 | 120 | 2 | C0004681 | |
| Disease | triacylglycerol 48:4 measurement | 1.45e-03 | 14 | 120 | 2 | EFO_0010407 | |
| Disease | hippocampal atrophy | 1.55e-03 | 56 | 120 | 3 | EFO_0005039 | |
| Disease | quinate measurement | 1.66e-03 | 15 | 120 | 2 | EFO_0021167 | |
| Disease | glycerate measurement | 1.66e-03 | 15 | 120 | 2 | EFO_0021029 | |
| Disease | Disorder of eye | 1.78e-03 | 212 | 120 | 5 | C0015397 | |
| Disease | esterified cholesterol measurement | 1.88e-03 | 128 | 120 | 4 | EFO_0008589 | |
| Disease | behavioural inhibitory control measurement | 1.90e-03 | 16 | 120 | 2 | EFO_0008467 | |
| Disease | SARS-CoV-2 antibody measurement, response to COVID-19 vaccine | 2.08e-03 | 62 | 120 | 3 | EFO_0803360, EFO_0803362 | |
| Disease | response to radiation, Urinary retention | 2.14e-03 | 17 | 120 | 2 | GO_0009314, HP_0000016 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 2.40e-03 | 447 | 120 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | Tourette syndrome, schizophrenia | 2.40e-03 | 18 | 120 | 2 | EFO_0004895, MONDO_0005090 | |
| Disease | common carotid intimal medial thickness | 2.60e-03 | 67 | 120 | 3 | EFO_0004860 | |
| Disease | triglycerides to phosphoglycerides ratio | 2.71e-03 | 68 | 120 | 3 | EFO_0022327 | |
| Disease | Familial aplasia of the vermis | 2.97e-03 | 20 | 120 | 2 | cv:C0431399 | |
| Disease | saturated fatty acids to total fatty acids percentage | 3.27e-03 | 21 | 120 | 2 | EFO_0022305 | |
| Disease | lung cancer (is_implicated_in) | 3.45e-03 | 74 | 120 | 3 | DOID:1324 (is_implicated_in) | |
| Disease | non-small cell lung carcinoma | 3.58e-03 | 75 | 120 | 3 | EFO_0003060 | |
| Disease | Kidney Failure | 3.59e-03 | 22 | 120 | 2 | C0035078 | |
| Disease | lung carcinoma | 3.63e-03 | 482 | 120 | 7 | EFO_0001071 | |
| Disease | sleep duration | 3.70e-03 | 362 | 120 | 6 | EFO_0005271 | |
| Disease | Nonsyndromic genetic hearing loss | 3.72e-03 | 76 | 120 | 3 | cv:C5680182 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LETVVRTVPGLLQTV | 481 | Q7Z4L5 | |
| LEPIAIGLLIIVIAS | 191 | O43315 | |
| ILPISVGVINLLIVE | 226 | Q8N8Q8 | |
| SPTELIAVEGTEILQ | 2916 | P13611 | |
| SLSVVVSLLLIPEDV | 11 | P12544 | |
| SEEVGSLRPLTVVIL | 36 | O75388 | |
| VPIVISLTLTTLLGN | 111 | Q9UGQ2 | |
| EDPVLTVITQVGLTI | 186 | Q86SQ3 | |
| SLPVLVVVLSIVLEG | 6 | P02654 | |
| LTVPVLQLGVLISDS | 1476 | Q8IYW2 | |
| LLLITEIIPSTSLVI | 311 | Q15822 | |
| VIPILDSLLTAGIIN | 461 | Q13489 | |
| SVPGLLEIILSSSIL | 606 | Q4L235 | |
| LIIIILQSIPDISTL | 166 | O60423 | |
| LTPVTLVLAEDGTIV | 56 | O00273 | |
| IVLATNIAETGITIP | 926 | Q7Z478 | |
| AVVLLVESITPVGSL | 181 | O75907 | |
| VTVNSILGIISVPLS | 186 | Q9Y394 | |
| TVPLSGTAIVTILID | 2151 | Q9H251 | |
| NNLIPISLLVTLEVV | 371 | Q9NTI2 | |
| VVVSLILLEQEPGGL | 341 | Q8TE60 | |
| VNVPLQTTLGTLEEI | 496 | Q16515 | |
| SVSLIILLTDGDPTV | 376 | Q14624 | |
| VSQELLDTVLVNLVP | 191 | Q9NTI5 | |
| IPENTLVGTRILTVT | 251 | Q9Y5H1 | |
| LIPKGTDVITLLNTV | 381 | P24903 | |
| ELTGTVQLLVTVLDV | 221 | Q9UN73 | |
| TIPIVLTQQELAALV | 1681 | P51610 | |
| ELTGTVQLLVTVLDV | 221 | Q9Y5H6 | |
| VTVQLLDLGLTITPE | 606 | O60309 | |
| VVVSTDILTPNGLTI | 2356 | Q9NZR2 | |
| LEITILTSQPGKEVV | 141 | Q8TC57 | |
| LLEVNETPVAGLTIR | 66 | Q86UL8 | |
| VTVQLLDLGLTITPE | 606 | A6NM11 | |
| VTVQLLDLGLTITPE | 606 | A6NMS7 | |
| IVTPLTSLVIENEAG | 621 | P19823 | |
| EILNTPLLTVQEGAV | 141 | Q9Y2Z2 | |
| VLEILLSTGSLVIPA | 1661 | Q03001 | |
| SAIIELVETLQALPT | 291 | O95382 | |
| LPIVTAIGDLIGILE | 191 | Q9Y233 | |
| ALTDLVGQLLTTPVV | 96 | P43115 | |
| LAVTDLLGTLLVSPV | 61 | P35408 | |
| PTIVSVEILTVALDG | 96 | Q9BY08 | |
| VPVIISSSILLLGTL | 846 | P48357 | |
| EALEILSAITQPVVV | 26 | Q96PP8 | |
| EALEILSAITQPVVV | 26 | Q8N8V2 | |
| VIVDATTGLIPLTSV | 906 | Q9ULI3 | |
| ILLGLTDVPELQVAV | 11 | Q8NGE2 | |
| IVGNITILVVVATEP | 41 | Q8NH57 | |
| PRSGTVQILILVLDA | 221 | Q9Y5E8 | |
| VLEPIQSTSLIGTLT | 636 | Q6ZMI0 | |
| DTIPTSVLLQVVELL | 2721 | Q9Y4D8 | |
| IISELVSISELAQPL | 651 | P78344 | |
| TLLSVINAVILGPED | 196 | Q27J81 | |
| PEEISGLTSLTDLVI | 236 | Q9BTT6 | |
| ILEDGTLLVIASVTP | 1316 | Q96RW7 | |
| ILLGLTDDPQLQVII | 11 | A6NCV1 | |
| VLVPETGIILENTLL | 476 | Q9UMZ3 | |
| ELTGTVQLLITILDV | 221 | Q9Y5I0 | |
| TIILLGSSPLEQEIR | 181 | Q8IZS5 | |
| VLVEENLPAGTTILQ | 826 | Q96QU1 | |
| TVILLDIEGTTTPIA | 11 | Q9UHY7 | |
| ETVEPIISQLVTVLL | 1326 | Q13535 | |
| NLPTILVEITATVLD | 571 | Q9ULT8 | |
| SPLIQEASIGLLEIV | 436 | Q9P2D3 | |
| VDQLVEIIKVLGTPT | 326 | P49840 | |
| IVEEEVPNISILGLS | 996 | Q9P2K1 | |
| VIPGDLPLIQEVTTT | 81 | Q14185 | |
| VIVLTSVGLPTDDIT | 431 | O00341 | |
| SVGLPTDDITLIIAV | 436 | O00341 | |
| NTVALTTPIAELLIV | 211 | Q9BWC9 | |
| LLILTAVGLPTEDIS | 451 | P43004 | |
| AVGLPTEDISLLVAV | 456 | P43004 | |
| VETLISSLKPIGNIV | 1296 | Q9P0X4 | |
| SRITEGVPQLLIVLT | 1126 | P12111 | |
| LVTPTEEGLRVLTQL | 66 | P98187 | |
| LSEASLIGTPVLQVV | 2296 | Q8TDW7 | |
| LIGTPVLQVVSIDAD | 2301 | Q8TDW7 | |
| LTVVGKEPESILQVL | 271 | P17174 | |
| TSVGLPTEDITLIIA | 481 | P48664 | |
| IENPVLENTSVISLL | 1436 | Q5T890 | |
| STGINITTVAIPLVL | 451 | Q8N8Z6 | |
| ETLISSLRPIGNIVL | 1421 | O95180 | |
| TGLSPTSVVLLQELE | 4226 | Q8IVF4 | |
| EGLPLLITLDSVLQT | 3151 | Q9NZJ4 | |
| ISIENKTTEIPLIGL | 121 | Q6ZTR5 | |
| DLDLGIGQIITISIT | 386 | P43005 | |
| IVLSAVGLPAEDVTL | 421 | P43005 | |
| APETVLQLTLENTVL | 101 | E9PI22 | |
| LQLTLENTVLVIVPE | 106 | E9PI22 | |
| PTINLLGELSVLVTT | 371 | P03905 | |
| LLIVVDIIASPSLGS | 41 | Q8NH83 | |
| LSTLNVLVTPELLET | 481 | P43121 | |
| EVGEEVISTLQILPT | 841 | O60469 | |
| TVLEGDNLETPITLI | 3156 | P46939 | |
| TSVLVGPLVSNLEIT | 216 | Q9UQF0 | |
| TRLISDPVLLVGTTI | 816 | Q9BYH1 | |
| LIVLTGSESPIVVVL | 51 | Q9BY50 | |
| IGTLALSLTIPLSII | 426 | Q8WV83 | |
| PEVILTLSLISSIGA | 16 | Q4G0N8 | |
| LPLQIEVSDTELSQI | 526 | Q8N3T6 | |
| VSPLTEAVLGETLLT | 661 | Q6IEE7 | |
| VNLLGVIDVTLSLLP | 136 | O75452 | |
| IESVLITIPVQLLIT | 1431 | Q9NTG1 | |
| VDTLSTNVIPDILII | 336 | Q9HCL2 | |
| VVPESALLIVLGLVL | 81 | P48764 | |
| EIDPVTLNLIILVAS | 6 | A0A1B0GVT2 | |
| SNILEELVVQPLLVS | 501 | P50991 | |
| ELVVQPLLVSVSALT | 506 | P50991 | |
| LILDTTVSDPNLVGI | 396 | Q96JW4 | |
| PIISGVLLATVTELS | 171 | Q96K37 | |
| DVIGLPELVIQLATS | 971 | Q12769 | |
| LLTDTLELTLGVTPE | 191 | Q9NPQ8 | |
| APETVLQLTLENTVL | 101 | P0DMB1 | |
| LQLTLENTVLVIVPE | 106 | P0DMB1 | |
| ILLGLTDDPQLQIVI | 11 | A6NF89 | |
| ILATAGNVVTLTIIP | 251 | Q9H190 | |
| TVEAVITPLLDVGVL | 421 | Q96N87 | |
| LDEQTSLLVLVPAGV | 341 | Q96KA5 | |
| GITIVVSPLIALIQD | 71 | O94762 | |
| PVLEVLVGKTIEQSL | 316 | Q86UC2 | |
| GIPELIELLTSQISI | 201 | P57772 | |
| RSLVPTEDLVGIISI | 2321 | Q15413 | |
| ILTNTEIPLQLVTVS | 761 | Q02447 | |
| QETLLAPVRLTGLVT | 141 | A6NE52 | |
| GPIDLITVGSLIELQ | 181 | Q5VUG0 | |
| NVISVITETLLEVLP | 436 | Q8IWV7 | |
| LEIEVLNTLGVTVLS | 186 | Q9UH36 | |
| ITPSTGTVNELITII | 1571 | Q86WI1 | |
| PEGIVAISTNTLRIL | 751 | Q15393 | |
| ITTLLVDLGTPQAEI | 321 | Q92797 | |
| VLSSIETGVSIIIPQ | 1646 | Q07157 | |
| SLLVVEPTGQAIIAI | 131 | Q92536 | |
| SLGLISVDVRIPEQI | 1576 | Q12789 | |
| AAIITLLVSDPVGVL | 101 | Q9P055 | |
| LGSSAPEILLSVIEV | 136 | Q9UPR5 |